| Title | Lung Cancer |
| Abbreviation | Lung Cancer |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cancer Research (Q1); Oncology (Q1); Pulmonary and Respiratory Medicine (Q1) |
| h-index | 148 |
| Overall Rank/Ranking | 1702 |
| SCImago Journal Rank (SJR) | 1.761 |
| Impact Score | 4.16 |
| Publisher | Elsevier Ireland Ltd |
| Country | Ireland |
| ISSN | 01695002, 18728332 |
| Best Quartile | Q1 |
| Coverage History | 1985-2023 |
Lung Cancer is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Oncology (Q1); Pulmonary and Respiratory Medicine (Q1). It is published by Elsevier Ireland Ltd. The overall rank of Lung Cancer is 1702. According to SCImago Journal Rank (SJR), this journal is ranked 1.761. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 148. The best quartile for this journal is Q1.
The ISSN of Lung Cancer journal is 01695002, 18728332. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Lung Cancer is cited by a total of 3811 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Lung Cancer is 4.16, which is computed in 2024 as per its definition. Lung Cancer IF is decreased by a factor of 0.28 and approximate percentage change is -6.31% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Lung Cancer is 4.16. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4.16 |
| 2022 | 4.44 |
| 2021 | 5.30 |
| 2020 | 4.75 |
| 2019 | 4.27 |
| 2018 | 4.54 |
| 2017 | 4.57 |
| 2016 | 4.53 |
| 2015 | 4.36 |
| 2014 | 4.48 |
Lung Cancer has an h-index of 148. It means 148 articles of this journal have more than 148 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Lung Cancer is 01695002, 18728332. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Lung Cancer is 1702. According to SCImago Journal Rank (SJR), this journal is ranked 1.761. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.761 |
| 2022 | 1.609 |
| 2021 | 1.399 |
| 2020 | 1.989 |
| 2019 | 1.705 |
| 2018 | 1.905 |
| 2017 | 1.750 |
| 2016 | 1.703 |
| 2015 | 1.885 |
| 2014 | 1.764 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1702 |
| 2022 | 1904 |
| 2021 | 2362 |
| 2020 | 1325 |
| 2019 | 1769 |
| 2018 | 1494 |
| 2017 | 1741 |
| 2016 | 1893 |
| 2015 | 1619 |
| 2014 | 1760 |
Lung Cancer is published by Elsevier Ireland Ltd. It's publishing house is located in Ireland. Coverage history of this journal is as following: 1985-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Lung Cancer is Lung Cancer. This abbreviation ('Lung Cancer') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q1); Oncology (Q1); Pulmonary and Respiratory Medicine (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Lung Cancer latest impact IF is 4.16. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 5.30 (2021) and 4.16 (2023), respectively, in the last 10 years. Moreover, its average IS is 4.54 in the previous 10 years.
The Lung Cancer has an SJR (SCImago Journal Rank) of 1.761, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.989 in 2020 and the lowest being 1.399 in 2021. Furthermore, the average SJR of the Lung Cancer over the previous 10-year period stands at 4.54.
The latest h-index of the Lung Cancer is 148.
The Lung Cancer is published by the Elsevier Ireland Ltd, with its country of publication being the Ireland.
The Lung Cancer is currently ranked 1702 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 1325 in 2020 and its lowest position of 2362 in 2021.
The standard ISO4 abbreviation for the Lung Cancer is Lung Cancer.
Lung Cancer is classified as a journal that the Elsevier Ireland Ltd publishes.
The Lung Cancer encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Lung Cancer is assigned the following International Standard Serial Numbers (ISSN): 01695002, 18728332.
The best quartile for the Lung Cancer is Q1 (2023).
The Lung Cancer coverage history can be summarized as follows: 1985-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Indian Journal of Plastic Surgery | journal | 13847 | Thieme Medical Publishers, Inc. | 40 | 0.59 |
| Journal of Academic Ethics | journal | 10291 | Springer Netherlands | 30 | 2.62 |
| European Union Politics | journal | 2569 | SAGE Publications Ltd | 75 | 3.24 |
| Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
| Archives of Phytopathology and Plant Protection | journal | 15268 | Taylor and Francis Ltd. | 33 | 1.39 |
| Educational Measurement: Issues and Practice | journal | 5979 | Wiley-Blackwell Publishing Ltd | 64 | 1.67 |
| Sapporo Medical Journal | journal | 27142 | 3 | 0.00 | |
| Indian Phytopathology | journal | 15501 | Springer Nature | 16 | 1.09 |
| Asian Textile Journal | trade journal | 27997 | G P S Kwatra | 11 | 0.03 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 4.16 |
| 2022 | 4.44 |
| 2021 | 5.30 |
| 2020 | 4.75 |
| 2019 | 4.27 |
| 2018 | 4.54 |
| 2017 | 4.57 |
| 2016 | 4.53 |
| 2015 | 4.36 |
| 2014 | 4.48 |
